[The immunocorrective activity of myelopeptide-1 and myelopeptide-2 in cyclophosphane-treated mice].
Shanurin
S Iu
SIu
Belevskaia
R G
RG
Mikhaĭlova
A A
AA
Shanurin
M Iu
MIu
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001853:Bone Marrow / Q000276:immunology*; D002455:Cell Division; D003520:Cyclophosphamide / Q000494:pharmacology*; D005260:Female; D007111:Immunity, Cellular / Q000187:drug effects; D007114:Immunization; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009842:Oligopeptides; D010455:Peptides / Q000494:pharmacology*; D010587:Phagocytosis / Q000187:drug effects; D013154:Spleen / Q000166:cytology / Q000187:drug effects
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents; D009842:Oligopeptides; D010455:Peptides; C048617:myelopeptides; D003520:Cyclophosphamide
Izuchenie immunokorrigiruiushcheĭ aktivnosti mielopeptida-1 i mielopeptida-2 u mysheĭ, obrabotannykh tsiklofosfanom.